Hyperpigmentation of the flexures and pancytopenia during treatment with folate antagonists.
Jucgla
A
A
Sais
G
G
Berlanga
J
J
Servitje
O
O
D000293:Adolescent; D001365:Axilla; D005260:Female; D005493:Folic Acid Antagonists / Q000009:adverse effects* / Q000627:therapeutic use; D006801:Humans; D017495:Hyperpigmentation / Q000139:chemically induced* / Q000503:physiopathology; D010198:Pancytopenia / Q000139:chemically induced* / Q000503:physiopathology; D014126:Toxoplasmosis, Ocular / Q000188:drug therapy
D005493:Folic Acid Antagonists